CoChat

The “Iron”-y of Iron Overload and Iron Deficiency in Chronic Obstructive Pulmonary Disease

Open access
Cloonan, Suzanne M., Mumby, Sharon, Adcock, Ian M., Choi, Augustine M. K., Chung, Kian Fan, Quinlan, Gregory J. · 2017 · American Journal of Respiratory and Critical Care Medicine
Cited by 106

The DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.

Abstract

Chronic obstructive pulmonary disease (COPD) is a debilitating inflammatory lung disease associated with cigarette smoking and is third leading cause of death worldwide. With the recent emergence of genome wide association studies (GWAS), the identification of multiple COPD susceptibility genes has enhanced and expanded our understanding of the pathogenic mechanisms associated with this debilitating lung disease. An example of such a pathogenic mechanism is the role of iron metabolism in the onset and progression of COPD. Historic observations of iron dysregulation in COPD can now be enlightened by the recent revelations that genetic polymorphisms in the gene iron regulatory protein-2 (IRP-2) associate with COPD susceptibility. A functional role for IRP-2 is supported by IRP-2 overexpression in murine models, that demonstrates cellular and mitochondrial iron accumulation in the lung linked with manifestations of experimental COPD. Increased IRP2 may explain the excessive iron deposition in alveolar macrophages and tissue in smokers and in patients with COPD. Changes in IRP2 expression may also associate with systemic iron mismanagement, which may explain the prevalence of systemic iron deficiency and iron-deficiency anemia in patients with COPD. It may also help to explain why patients with COPD and/or iron deficiency manifest altered responses to hypoxia including erythropoiesis and pulmonary hypertension. We provide a concise review of the role of iron in the pathogenesis, susceptibility and progression of COPD and highlight the prospective therapeutic interventions for treating both local and systemic iron dysregulation.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1164/rccm.201702-0311pp

Cites

24 of 24 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 103

  1. Burney, 2015, Global and regional trends in COPD mortality, 1990–2010, Eur Respir J, 45, 1239, 10.1183/09031936.00142414 · DOI · Paper page
  2. Mannino, 2007, Global burden of COPD: risk factors, prevalence, and future trends, Lancet, 370, 765, 10.1016/S0140-6736(07)61380-4 · DOI · Paper page
  3. Decramer, 2012, Chronic obstructive pulmonary disease, Lancet, 379, 1341, 10.1016/S0140-6736(11)60968-9 · DOI · Paper page
  4. Mortimer, 2012, Household air pollution is a major avoidable risk factor for cardiorespiratory disease, Chest, 142, 1308, 10.1378/chest.12-1596 · DOI
  5. DeMeo, 2009, Integration of genomic and genetic approaches implicates IREB2 as a COPD susceptibility gene, Am J Hum Genet, 85, 493, 10.1016/j.ajhg.2009.09.004 · DOI · Paper page
  6. Chappell, 2011, The role of IREB2 and transforming growth factor β-1 genetic variants in COPD: a replication case-control study, BMC Med Genet, 12, 24, 10.1186/1471-2350-12-24 · DOI · Paper page
  7. Du, 2016, Association of IREB2 gene rs2568494 polymorphism with risk of chronic obstructive pulmonary disease: a meta-analysis, Med Sci Monit, 22, 177, 10.12659/MSM.894524 · DOI
  8. Ding, 2014, Association of genetic polymorphisms with chronic obstructive pulmonary disease in the Hainan population: a case-control study, Int J Chron Obstruct Pulmon Dis, 10, 7, 10.2147/COPD.S73042 · DOI
  9. Ghio, 2009, Disruption of iron homeostasis and lung disease, Biochim Biophys Acta, 1790, 731, 10.1016/j.bbagen.2008.11.004 · DOI
  10. Kurz, 2011, Cell sensitivity to oxidative stress is influenced by ferritin autophagy, Free Radic Biol Med, 50, 1647, 10.1016/j.freeradbiomed.2011.03.014 · DOI
  11. Ito, 2015, PARK2-mediated mitophagy is involved in regulation of HBEC senescence in COPD pathogenesis, Autophagy, 11, 547, 10.1080/15548627.2015.1017190 · DOI · Paper page
  12. John, 2006, Prevalence of anemia in chronic obstructive pulmonary disease: comparison to other chronic diseases, Int J Cardiol, 111, 365, 10.1016/j.ijcard.2005.07.043 · DOI
  13. Martinez-Rivera, 2012, Anemia is a mortality predictor in hospitalized patients for COPD exacerbation, COPD, 9, 243, 10.3109/15412555.2011.647131 · DOI
  14. Boutou, 2013, Anemia and survival in chronic obstructive pulmonary disease: a dichotomous rather than a continuous predictor, Respiration, 85, 126, 10.1159/000338792 · DOI
  15. Nickol, 2015, A cross-sectional study of the prevalence and associations of iron deficiency in a cohort of patients with chronic obstructive pulmonary disease, BMJ Open, 5, e007911, 10.1136/bmjopen-2015-007911 · DOI · Paper page
  16. Mackay, 2015, Serum amyloid A and hepcidin elevations characterise bacterial-associated exacerbations in frequently exacerbating COPD patients [abstract], Am J Respir Crit Care Med, 191, A6336
  17. Takemoto, 1991, Metal concentrations in human lung tissue, with special reference to age, sex, cause of death, emphysema and contamination of lung tissue, Int Arch Occup Environ Health, 62, 579, 10.1007/BF00381111 · DOI
  18. Díez, 1989, Serum and tissue trace metal levels in lung cancer, Oncology, 46, 230, 10.1159/000226722 · DOI · Paper page
  19. Sirlin, 2010, Magnetic resonance imaging quantification of liver iron, Magn Reson Imaging Clin N Am, 18, 359, 10.1016/j.mric.2010.08.014 · DOI · Paper page
  20. Van Eijk, 1974, Measurement of the iron content in human liver specimens, Clin Chim Acta, 50, 275, 10.1016/0009-8981(74)90375-1 · DOI
  21. Carpenter, 2011, On T2* magnetic resonance and cardiac iron, Circulation, 123, 1519, 10.1161/CIRCULATIONAHA.110.007641 · DOI · Paper page
  22. World Health Organization (WHO)., 1996, Guidelines for drinking-water quality
  23. Kim, 2011, Influence of DMT1 and iron status on inflammatory responses in the lung, Am J Physiol Lung Cell Mol Physiol, 300, L659, 10.1152/ajplung.00343.2010 · DOI
  24. Du, 2015, ‘LungGENS’: a web-based tool for mapping single-cell gene expression in the developing lung, Thorax, 70, 1092, 10.1136/thoraxjnl-2015-207035 · DOI · Paper page
  25. Lindskog, 2014, The lung-specific proteome defined by integration of transcriptomics and antibody-based profiling, FASEB J, 28, 5184, 10.1096/fj.14-254862 · DOI · Paper page
  26. Heilig, 2006, Manganese and iron transport across pulmonary epithelium, Am J Physiol Lung Cell Mol Physiol, 290, L1247, 10.1152/ajplung.00450.2005 · DOI · Paper page
  27. Wu, 2011, Advanced glycation end products and its receptor (RAGE) are increased in patients with COPD, Respir Med, 105, 329, 10.1016/j.rmed.2010.11.001 · DOI
  28. Cloonan, 2016, Mitochondrial iron chelation ameliorates cigarette smoke-induced bronchitis and emphysema in mice, Nat Med, 22, 163, 10.1038/nm.4021 · DOI · Paper page
  29. Szabó, 1980, Local production of proteins in normal human bronchial secretion, Respiration, 39, 172, 10.1159/000194213 · DOI
  30. Fracchia, 1999, A comparative study on ferritin concentration in serum and bilateral bronchoalveolar lavage fluid of patients with peripheral lung cancer versus control subjects, Oncology, 56, 181, 10.1159/000011962 · DOI
  31. Ghio, 1999, Respiratory epithelial cells demonstrate lactoferrin receptors that increase after metal exposure, Am J Physiol, 276, L933
  32. Kono, 2010, Biological effects of mutant ceruloplasmin on hepcidin-mediated internalization of ferroportin, Biochim Biophys Acta, 1802, 968, 10.1016/j.bbadis.2010.07.011 · DOI
  33. Iwamoto, 2014, Differences in plasma and sputum biomarkers between COPD and COPD–asthma overlap, Eur Respir J, 43, 421, 10.1183/09031936.00024313 · DOI
  34. Carraway, 1998, Induction of ferritin and heme oxygenase-1 by endotoxin in the lung, Am J Physiol, 275, L583
  35. Damron, 2016, Dual-seq transcriptomics reveals the battle for iron during Pseudomonas aeruginosa acute murine pneumonia, Sci Rep, 6, 39172, 10.1038/srep39172 · DOI · Paper page
  36. Galván-Peña, 2014, Metabolic reprograming in macrophage polarization, Front Immunol, 5, 420
  37. Thompson, 1991, Lower respiratory tract iron burden is increased in association with cigarette smoking, J Lab Clin Med, 117, 493
  38. Mussalo-Rauhamaa, 1986, Cigarettes as a source of some trace and heavy metals and pesticides in man, Arch Environ Health, 41, 49, 10.1080/00039896.1986.9935765 · DOI · Paper page
  39. Ghio, 2008, Particulate matter in cigarette smoke alters iron homeostasis to produce a biological effect, Am J Respir Crit Care Med, 178, 1130, 10.1164/rccm.200802-334OC · DOI · Paper page
  40. Corhay, 1992, Iron content in human alveolar macrophages, Eur Respir J, 5, 804, 10.1183/09031936.93.05070804 · DOI · Paper page
  41. McGowan, 1988, Iron and ferritin contents and distribution in human alveolar macrophages, J Lab Clin Med, 111, 611
  42. Philippot, 2014, Increased iron sequestration in alveolar macrophages in chronic obstructive pulmonary disease, PLoS One, 9, e96285, 10.1371/journal.pone.0096285 · DOI · Paper page
  43. Wesselius, 1992, Alveolar macrophage content of isoferritins and transferrin: comparison of nonsmokers and smokers with and without chronic airflow obstruction, Am Rev Respir Dis, 145, 311, 10.1164/ajrccm/145.2_Pt_1.311 · DOI · Paper page
  44. Wesselius, 1994, Increased release of ferritin and iron by iron-loaded alveolar macrophages in cigarette smokers, Am J Respir Crit Care Med, 150, 690, 10.1164/ajrccm.150.3.8087339 · DOI · Paper page
  45. Nelson, 1996, Regional variation in iron and iron-binding proteins within the lungs of smokers, Am J Respir Crit Care Med, 153, 1353, 10.1164/ajrccm.153.4.8616566 · DOI · Paper page
  46. Mumby, 2016, Decreased breath excretion of redox active iron in COPD: a protective failure?, Eur Respir J, 47, 1267, 10.1183/13993003.01710-2015 · DOI · Paper page
  47. Lee, 2016, Association of serum ferritin levels with smoking and lung function in the Korean adult population: analysis of the fourth and fifth Korean National Health and Nutrition Examination Survey, Int J Chron Obstruct Pulmon Dis, 11, 3001, 10.2147/COPD.S116982 · DOI
  48. Shibata, 2013, Elevated serum iron is a potent biomarker for spirometric resistance to cigarette smoke among Japanese males: the Takahata study, PLoS One, 8, e74020, 10.1371/journal.pone.0074020 · DOI
  49. McKeever, 2008, A multivariate analysis of serum nutrient levels and lung function, Respir Res, 9, 67, 10.1186/1465-9921-9-67 · DOI · Paper page
  50. Nordenberg, 1990, The effect of cigarette smoking on hemoglobin levels and anemia screening, JAMA, 264, 1556, 10.1001/jama.1990.03450120068031 · DOI · Paper page
  51. Sadreameli, 2016, Secondhand smoke is an important modifiable risk factor in sickle cell disease: a review of the current literature and areas for future research, Int J Environ Res Public Health, 13, 1131, 10.3390/ijerph13111131 · DOI
  52. Cohen, 2013, Environmental tobacco smoke and airway obstruction in children with sickle cell anemia, Chest, 144, 1323, 10.1378/chest.12-1569 · DOI
  53. Pacht, 1988, Decreased ceruloplasmin ferroxidase activity in cigarette smokers, J Lab Clin Med, 111, 661
  54. Ingebrigtsen, 2010, Genetic influences on chronic obstructive pulmonary disease – a twin study, Respir Med, 104, 1890, 10.1016/j.rmed.2010.05.004 · DOI
  55. Lee, 2015, IREB2 and GALC are associated with pulmonary artery enlargement in chronic obstructive pulmonary disease, Am J Respir Cell Mol Biol, 52, 365, 10.1165/rcmb.2014-0210OC · DOI
  56. Kim, 2012, Association of IREB2 and CHRNA3 polymorphisms with airflow obstruction in severe alpha-1 antitrypsin deficiency, Respir Res, 13, 16, 10.1186/1465-9921-13-16 · DOI
  57. Siedlinski, 2013, Dissecting direct and indirect genetic effects on chronic obstructive pulmonary disease (COPD) susceptibility, Hum Genet, 132, 431, 10.1007/s00439-012-1262-3 · DOI
  58. Zhou, 2012, Association of IREB2 and CHRNA3/5 polymorphisms with COPD and COPD-related phenotypes in a Chinese Han population, J Hum Genet, 57, 738, 10.1038/jhg.2012.104 · DOI
  59. Ziółkowska-Suchanek, 2015, Susceptibility loci in lung cancer and COPD: association of IREB2 and FAM13A with pulmonary diseases, Sci Rep, 5, 13502, 10.1038/srep13502 · DOI
  60. Liu, 2016, Focused analysis of exome sequencing data for rare germline mutations in familial and sporadic lung cancer, J Thorac Oncol, 11, 52, 10.1016/j.jtho.2015.09.015 · DOI
  61. Pillai, 2009, A genome-wide association study in chronic obstructive pulmonary disease (COPD): identification of two major susceptibility loci, PLoS Genet, 5, e1000421, 10.1371/journal.pgen.1000421 · DOI · Paper page
  62. He, 2009, Associations of IL6 polymorphisms with lung function decline and COPD, Thorax, 64, 698, 10.1136/thx.2008.111278 · DOI
  63. Ghio, 2013, Deficiency of α-1-antitrypsin influences systemic iron homeostasis, Int J Chron Obstruct Pulmon Dis, 8, 45, 10.2147/COPD.S37897 · DOI
  64. Fischer, 2009, Neutrophil elastase increases airway epithelial nonheme iron levels, Clin Transl Sci, 2, 333, 10.1111/j.1752-8062.2009.00151.x · DOI
  65. Lam, 2010, HFE mutations in alpha-1-antitrypsin deficiency: an examination of cirrhotic explants, Mod Pathol, 23, 637, 10.1038/modpathol.2010.42 · DOI
  66. Linet, 1999, Primary liver cancer, other malignancies, and mortality risks following porphyria: a cohort study in Denmark and Sweden, Am J Epidemiol, 149, 1010, 10.1093/oxfordjournals.aje.a009745 · doi:10.1093/oxfordjournals.aje.a009745
  67. Bala, 2010, Chronic obstructive pulmonary disease in iron-steel and ferrochrome industry workers, Cent Eur J Public Health, 18, 93, 10.21101/cejph.a3548 · DOI
  68. Hedlund, 2006, Persistence of respiratory symptoms in ex-underground iron ore miners, Occup Med (Lond), 56, 380, 10.1093/occmed/kql035 · DOI
  69. Adelroth, 2006, Airway inflammation in iron ore miners exposed to dust and diesel exhaust, Eur Respir J, 27, 714, 10.1183/09031936.06.00034705 · doi:10.1183/09031936.06.00034705
  70. Hedlund, 2004, Respiratory symptoms and obstructive lung diseases in iron ore miners: report from the obstructive lung disease in northern Sweden studies, Eur J Epidemiol, 19, 953, 10.1007/s10654-004-5194-7 · DOI
  71. Hirayama, 2010, Dietary intake of six minerals in relation to the risk of chronic obstructive pulmonary disease, Asia Pac J Clin Nutr, 19, 572
  72. Dickens, 2011, COPD association and repeatability of blood biomarkers in the ECLIPSE cohort, Respir Res, 12, 146, 10.1186/1465-9921-12-146 · DOI · Paper page
  73. Portillo, 2013, Anaemia in chronic obstructive pulmonary disease: does it really matter?, Int J Clin Pract, 67, 558, 10.1111/ijcp.12125 · DOI
  74. Tandara, 2015, Systemic inflammation up-regulates serum hepcidin in exacerbations and stabile chronic obstructive pulmonary disease, Clin Biochem, 48, 1252, 10.1016/j.clinbiochem.2015.07.010 · DOI
  75. Silverberg, 2014, Anemia and iron deficiency in COPD patients: prevalence and the effects of correction of the anemia with erythropoiesis stimulating agents and intravenous iron, BMC Pulm Med, 14, 24, 10.1186/1471-2466-14-24 · DOI
  76. Plesner, 2017, Iron deficiency in COPD associates with increased pulmonary artery pressure estimated by echocardiography, Heart Lung Circ, 26, 101, 10.1016/j.hlc.2016.04.020 · DOI
  77. Frise, 2016, Clinical iron deficiency disturbs normal human responses to hypoxia, J Clin Invest, 126, 2139, 10.1172/JCI85715 · DOI · Paper page
  78. Boutou, 2015, Non-anaemic iron deficiency in COPD: a potential therapeutic target?, Respirology, 20, 1004, 10.1111/resp.12616 · DOI
  79. Barberan-Garcia, 2015, Non-anaemic iron deficiency impairs response to pulmonary rehabilitation in COPD, Respirology, 20, 1089, 10.1111/resp.12591 · DOI
  80. Chen, 2012, Cellular and mitochondrial iron homeostasis in vertebrates, Biochim Biophys Acta, 1823, 1459, 10.1016/j.bbamcr.2012.01.003 · DOI · Paper page
  81. Chung, 2008, Multifaceted mechanisms in COPD: inflammation, immunity, and tissue repair and destruction, Eur Respir J, 31, 1334, 10.1183/09031936.00018908 · DOI · Paper page
  82. Wiegman, 2015, Oxidative stress-induced mitochondrial dysfunction drives inflammation and airway smooth muscle remodeling in patients with chronic obstructive pulmonary disease, J Allergy Clin Immunol, 136, 769, 10.1016/j.jaci.2015.01.046 · DOI · Paper page
  83. Rahman, 2006, Oxidative stress and redox regulation of lung inflammation in COPD, Eur Respir J, 28, 219, 10.1183/09031936.06.00053805 · DOI · Paper page
  84. Kamp, 1998, Cigarette smoke augments asbestos-induced alveolar epithelial cell injury: role of free radicals, Free Radic Biol Med, 25, 728, 10.1016/S0891-5849(98)00158-0 · DOI · Paper page
  85. Wesselius, 1999, Iron uptake promotes hyperoxic injury to alveolar macrophages, Am J Respir Crit Care Med, 159, 100, 10.1164/ajrccm.159.1.9801033 · DOI
  86. Dai, 2002, Iron loading makes a nonfibrogenic model air pollutant particle fibrogenic in rat tracheal explants, Am J Respir Cell Mol Biol, 26, 685, 10.1165/ajrcmb.26.6.4651 · DOI · Paper page
  87. Smith, 2010, Inflammatory response of lung macrophages and epithelial cells to tobacco smoke: a literature review of ex vivo investigations, Immunol Res, 46, 94, 10.1007/s12026-009-8133-6 · DOI
  88. Gally, 2013, Cigarette smoke decreases airway epithelial FABP5 expression and promotes Pseudomonas aeruginosa infection, PLoS One, 8, e51784, 10.1371/journal.pone.0051784 · DOI
  89. Brunk, 2001, Lysosomal involvement in apoptosis, Redox Rep, 6, 91, 10.1179/135100001101536094 · DOI · Paper page
  90. Yatmark, 2015, Effects of iron chelators on pulmonary iron overload and oxidative stress in β-thalassemic mice, Pharmacology, 96, 192, 10.1159/000438994 · DOI
  91. Filosa, 2013, Long-term treatment with deferiprone enhances left ventricular ejection function when compared to deferoxamine in patients with thalassemia major, Blood Cells Mol Dis, 51, 85, 10.1016/j.bcmd.2013.04.002 · DOI
  92. Schönhofer, 1998, Blood transfusion and lung function in chronically anemic patients with severe chronic obstructive pulmonary disease, Crit Care Med, 26, 1824, 10.1097/00003246-199811000-00022 · DOI
  93. Schönhofer, 1998, Blood transfusion facilitating difficult weaning from the ventilator, Anaesthesia, 53, 181, 10.1046/j.1365-2044.1998.00275.x · DOI · Paper page
  94. John, 2005, Anemia and inflammation in COPD, Chest, 127, 825, 10.1378/chest.127.3.825 · DOI · Paper page
  95. Tassiopoulos, 2001, Erythropoietic response to hypoxaemia in diffuse idiopathic pulmonary fibrosis, as opposed to chronic obstructive pulmonary disease, Respir Med, 95, 471, 10.1053/rmed.2001.1070 · doi:10.1053/rmed.2001.1070
  96. Sala, 2010, Low erythropoietin plasma levels during exacerbations of COPD, Respiration, 80, 190, 10.1159/000264604 · DOI
  97. Smith, 2008, The increase in pulmonary arterial pressure caused by hypoxia depends on iron status, J Physiol, 586, 5999, 10.1113/jphysiol.2008.160960 · DOI · Paper page
  98. Schoos, 2013, Echocardiographic predictors of exercise capacity and mortality in chronic obstructive pulmonary disease, BMC Cardiovasc Disord, 13, 84, 10.1186/1471-2261-13-84 · DOI
  99. Steinbicker, 2013, Out of balance—systemic iron homeostasis in iron-related disorders, Nutrients, 5, 3034, 10.3390/nu5083034 · DOI · Paper page
  100. Van Buren, 2012, Iron overdose: a contributor to adverse outcomes in randomized trials of anemia correction in CKD, Int Urol Nephrol, 44, 499, 10.1007/s11255-011-0028-5 · DOI
  101. DePalma, 2013, Reduction of iron stores and clinical outcomes in peripheral arterial disease: outcome comparisons in smokers and non-smokers, Vascular, 21, 233, 10.1177/1708538113478776 · DOI
  102. Martinez, 1997, Iron stores and coagulation parameters in patients with hypoxemic polycythemia secondary to chronic obstructive pulmonary disease: the effect of phlebotomies, Sao Paulo Med J, 115, 1395, 10.1590/S1516-31801997000200005 · DOI
  103. Chetty, 1990, Exercise performance of polycythemic chronic obstructive pulmonary disease patients. Effect of phlebotomies, Chest, 98, 1073, 10.1378/chest.98.5.1073 · DOI

Cited by

See all 106

Metadata

Authors
Cloonan, S. M., Mumby, S., Adcock, I. M., Choi, A. M. K., Chung, K. F., & Quinlan, G. J.
Venue
American Journal of Respiratory and Critical Care Medicine
Published
2017-11-01
Volume
196
Issue
9
Pages
1103-1112
ISSN
  • 1073-449X (ISSN-L)
  • 1535-4970
OpenAlex
W2605628036
Cited by
106
References
24
FWCI
6.15
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.